In the latest session, Avenue Therapeutics Inc (NASDAQ: ATXI) closed at $0.15 down -4.49% from its previous closing price of $0.16. In other words, the price has decreased by -$0.0071 from its previous closing price. On the day, 1582541 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Avenue Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.55 and its Current Ratio is at 1.55. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 11 ’23 when Davidow Robert L sold 353,000 shares for $0.14 per share. The transaction valued at 49,600 led to the insider holds 22,000 shares of the business.
Davidow Robert L sold 264,000 shares of ATXI for $36,960 on Dec 11 ’23. The 10% Owner now owns 681,000 shares after completing the transaction at $0.14 per share. On Sep 08 ’23, another insider, Fortress Biotech, Inc., who serves as the 10% Owner of the company, bought 418,410 shares for $0.72 each. As a result, the insider paid 301,255 and bolstered with 1,032,390 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXI now has a Market Capitalization of 6.70M and an Enterprise Value of 4.92M.
Stock Price History:
Over the past 52 weeks, ATXI has reached a high of $1.36, while it has fallen to a 52-week low of $0.11. The 50-Day Moving Average of the stock is 0.1521, while the 200-Day Moving Average is calculated to be 0.5381.
Shares Statistics:
For the past three months, ATXI has traded an average of 5.45M shares per day and 1.78M over the past ten days. A total of 44.26M shares are outstanding, with a floating share count of 38.53M. Insiders hold about 12.96% of the company’s shares, while institutions hold 2.79% stake in the company. Shares short for ATXI as of Feb 29, 2024 were 163.46k with a Short Ratio of 0.03, compared to 677.27k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.44% and a Short% of Float of 0.44%.
Earnings Estimates
There are 1 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.12 for the current quarter, with a high estimate of -$0.12 and a low estimate of -$0.12, while EPS last year was -$1.35. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.41 and -$0.41 for the fiscal current year, implying an average EPS of -$0.41. EPS for the following year is -$0.37, with 1 analysts recommending between -$0.37 and -$0.37.
